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Abstract Expression of the manganese superoxide dismutase
(Mn-SOD) is induced by pro-inflammatory cytokines. We
investigated the cis-acting elements within a tumor necrosis
factor-responsive element (TNFRE) which was identified in the
second intron of the murine Mn-SOD gene. Site-directed
mutagenesis, reporter plasmid transfection studies and electro-
phoretic mobility shift assays demonstrated that inducible
transcription factors enhanced the transcriptional activity of
the Mn-SOD gene through the TNFRE. The cooperation
between proteins binding to the newly identified NF-UB and C/
EBP sites led to synergistic gene transcription. This report
provides the first evidence that cooperation between two distinct
cis-acting elements may be required for induction of Mn-SOD
gene expression mediated by lipopolysaccharide and interferon-Q.
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1. Introduction
The superoxide dismutases (SODs) are important metallo-
enzymes which scavenge superoxide radicals via disproportio-
nation [1]. Three types of SODs with distinctive distributions
are known to exist. The copper-zinc SOD (CuZn-SOD) is
found mainly in the cytosol of eukaryotes, the iron SOD
(Fe-SOD) is found in prokaryotes, eukaryotic algae and high-
er plants, and the manganese SOD (Mn-SOD) is found in
both prokaryotes and the mitochondria of eukaryotes. Ex-
pression of CuZn-SOD and Fe-SOD is constitutive, whereas
Mn-SOD is inducible by various stimuli, such as tumor ne-
crosis factor-K (TNF-K), interleukin-1 (IL-1), lipopolysaccha-
ride (LPS), interferon-Q (IFN-Q), or X-irradiation [2^4].
Recently, a TNF-responsive element (TNFRE) has been
identi¢ed within the second intron of the Mn-SOD gene
[5,6]. DNA-binding assays using TNFRE showed that C/
EBP L binds to the 5P region of the TNFRE and both C/
EBP L and NF-UB bind to the 3P region. Transfection assays
demonstrated that the 5P C/EBP-related region was responsive
to TNF, whereas the 3P NF-UB-related site was not [6].
To identify the critical cis-acting elements interacting with
NF-UB, we focused on a 30-bp region within the 5P C/EBP-
related region which responded to LPS and IFN-Q. Site-di-
rected mutagenesis, transfection studies, and electrophoretic
mobility shift assays were performed. We identi¢ed NF-UB
as a component of the inducible complex that binds to the
NF-UB binding site within the 5P C/EBP-related region. In
addition, the NF-UB site was shown to work in concert with
the C/EBP site to enhance gene transcription induced by ei-
ther LPS alone, or LPS in combination with IFN-Q.
2. Materials and methods
2.1. Materials
Cell culture reagents and calf serum (CS) were obtained from Gibco
BRL (Life Technologies Inc., New York, USA). Recombinant murine
IFN-Q was purchased from RpD Systems (Minneapolis, MN, USA),
LPS was from Sigma (St. Louis, MO, USA). Anti-C/EBP K, L and N,
anti-CRP-1, anti-p65 and p50 NF-UB antibodies and a NF-UB con-
sensus oligonucleotide were obtained from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). A rat Mn-SOD cDNA probe was a gift
from Dr. Ho (Wayne State University, Detroit, MI) [7]. A V genomic
library prepared from BamHI-, MboI-, BglII-, or Sau3A-digested
DNA isolated from the spleen cells of B6/CBA F1J mice was pur-
chased from Stratagene (La Jolla, CA, USA).
2.2. Cell culture
NIH3T3 cells were maintained in Dulbecco’s modi¢ed Eagle’s me-
dium supplemented with 10% CS, 100 U/ml penicillin, and 100 Wg/ml
streptomycin.
2.3. Plasmid construction
The genomic library was screened according to the standard proce-
dure with murine Mn-SOD probes recognizing distinct regions of
the gene. The plasmid constructions were generated by polymerase
chain reaction (PCR) ampli¢cation with the genomic Mn-SOD clone
as a template. The 5P primer (the positions of the 5P base are
indicated relative to the Mn-SOD transcription initiation site in pa-
rentheses) (+2119) 5P-CGCGGATCCGGGGGCATCTAGTGGAG-
AAG-3P was used with the 3P primer (+2420) 5P-TTTTGACGTC-
GACGCGAGCTCTGGCTCCACA-3P in a standard ampli¢cation
reaction with cycling temperatures of 94, 58, and 74‡C. The PCR
product was digested with BamHI and SalI, gel-puri¢ed, and ligated
into a BamHI-SalI-digested pGL3 promoter vector (Promega, Madi-
son, WI, USA). Plasmids containing mutations within the A site
(pGL3pro-mA) and the B site (pGL3pro-mB) were constructed using
the QuikChange Site-Directed Mutagenesis Kit (Stratagene) (Fig. 1B).
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The following pairs of oligonucleotides were used to create the mutant
sites (mutated residues are underlined): mA: 5P-CCAAGAGAGG-
GAAATGACTAGTCATTCTGGAAATTTTAC-3P, 5P-GTAAAAT-
TTCCAGAATGACTAGTCATTTCCCTCTCTTGG-3P, mB: 5P-CC-
ACATGACTAGTCTTTTACTTGC-3P, 5P-GCAAGTAAAAGACT-
AGTCATGTGG-3P. All plasmids were sequenced to con¢rm their
¢delity.
2.4. Transfection assays
Transient transfection of NIH3T3 cells was carried out using Super-
Fect reagent (Qiagen, Hilden, Germany). In general, the day before
transfection, 4U105 cells were plated in 12-well tissue culture plates,
which were supplemented with fresh medium before transfection. A
total of 2.5 Wg of DNA per plate was mixed with 10 Wl of SuperFect
reagent and allowed to form complexes for 15 min in serum- or anti-
biotics-free medium before being added to the cells. After transfec-
tion, the cells were placed in serum-free medium for 10 h, and then 0.1
or 1 Wg/ml LPS, 100 U/ml IFN-Q, both 1 Wg/ml LPS and 100 U/ml
IFN-Q, or control bu¡er was added for an additional 14 h. Cells were
harvested, and assayed by the Dual-Luciferase Reporter Assay System
(Promega) using a luminometer (E.G. and G. Berthold, Germany).
Promoter activities were expressed as relative light units (RLU), nor-
malized against the activity of the pRL-thymidine kinase (TK) control
vector (Promega).
2.5. Nuclear extract preparation
Nuclear extracts were prepared by the method described by Dignam
et al. [8]. In brief, cells with or without 4 h treatment with either or
both 0.1 Wg/ml LPS and 100 U/ml IFN-Q were washed twice in ice-
cold PBS, then suspended in bu¡er A (10 mM HEPES, pH 7.9, 1.5
mM MgCl2, 10 mM KCl, 0.5 mM DTT) and incubated on ice for 10
min. After centrifugation at 2000 rpm, the cell pellet was resuspended
in bu¡er A and lysed by ¢ve strokes with a glass Dounce homoge-
nizer. The nuclei were collected by centrifugation at 27 000 rpm for 20
min at 4‡C in an Optima TLX Ultracentrifuge rotor (Beckman). The
pellet was resuspended in bu¡er B (20 mM HEPES, pH 7.9, 25%
glycerol, 550 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM
DTT, 0.5 mM PMSF, 10 Wg/ml aprotinin, 10 Wg/ml pepstatin, and 10
Wg/ml leupeptin). The nuclear pellet was incubated on ice for 30 min,
followed by centrifugation at 27 000 rpm for 20 min. The supernatant
was dialyzed against bu¡er C (20 mM HEPES, pH 7.9, 20% glycerol,
0.1 M KCl, 0.2 mM EDTA, 0.5 mM DTT, and 0.5 mM PMSF) for
3 h at 4‡C. The dialysate was collected by centrifugation at 27 000
rpm for 20 min at 4‡C. The protein concentrations of the nuclear
fractions were determined by the Bradford assay with the Bio-Rad
protein assay dye reagent, and all extracts were stored at 370‡C.
2.6. Electrophoretic mobility shift assays (EMSA)
The DNA binding reaction was performed for 20 min at 4‡C in a
volume of 10 Wl, containing 1^2 Wg of nuclear extract, 2 Wl of 5Ubind-
ing bu¡er (1U : 10 mM Tris, pH 7.5, 4% glycerol, 1 mM MgCl2,
50 mM NaCl, 0.5 mM EDTA, 0.5 mM DTT, and 0.05 Wg/Wl poly-
(dI-dC)) with or without a 200-fold molar excess of an unlabeled
competitor DNA. Synthetic complementary oligonucleotides with a
G overhang were annealed and labeled with [K-32P]dCTP using the
Klenow fragment. The radiolabeled probe was added for an addition-
al incubation period of 20 min. For supershifts, nuclear extracts
were preincubated with antibodies for 20 min at 4‡C. DNA binding
reactions were separated on 5% native polyacrylamide gels. Gels were
dried, and subjected to autoradiography. The following pairs of
oligonucleotides were used (mutated residues are underlined) (Fig.
1C): SOD-C/EBP-UB: 5P-GGAAATATTACCACATTCTGGAAAT-
TTTAC-3P, 5P-GGGTAAAATTTCCAGAATGTGGTAATATTT-3P ;
SOD-UB, 5P-CACATTCTGGAAATTTTACTTGCAATAAG-3P, 5P-
GCTTATTGCAAGTAAAATTTCCAGAATGTG-3P ; Mut-UB, 5P-
CACATGACTAGTCTTTTACTTGCAATAAG-3P, 5P-GCTTATT-
GCAAGTAAAAGACTAGTCATGTG-3P.
3. Results
3.1. Determination of the regulatory DNA elements required
for transcriptional activity of the Mn-SOD enhancer
To test the e¡ects of LPS and IFN-Q on the enhancer ele-
ments of Mn-SOD, a 302-bp region (TNFRE) of intron 2
(+2119 to +2420) was subcloned into the pGL3 promoter
vector (pGL3pro), which contains the basic, enhancerless sim-
ian virus 40 promoter instead of the Mn-SOD promoter. Ly-
sates from the cells transfected with the pGL3pro produced
only low luciferase activity both in untreated cells and treated
cells. Lysates from the cells transfected with pGL3pro-WT
showed a 10-fold or 8-fold induction following treatment
with 0.1 or 1 Wg/ml LPS respectively, a 2-fold induction
with 100 U/ml IFN-Q alone, and a 15-fold induction with
1 Wg/ml LPS and 100 U/ml IFN-Q relative to the basal activity
Fig. 1. A: A schematic representation of the Mn-SOD enhancer. The locations of sites A and B are indicated by brackets. The positions of the
bases are indicated relative to the Mn-SOD transcription initiation site (+1). B: Sequences of wild-type and mutant Mn-SOD reporter vectors
transfected into the NIH3T3 cells, as well as the locations of the C/EBP- and NF-UB-binding sites. Wild-type enhancer sequences are indicated
by capital letters. A crossed out site indicates that the site has been mutated to a non-binding sequence, with the mutated sequence indicated
by lower-case letters. C: Sequences of the oligonucleotides for EMSA.
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of this construct in untreated cells (Fig. 2). These results were
consistent with those of the Northern blot analysis (data not
shown).
To determine which cis-elements show signi¢cant enhancer
activity, we focused on a 30-bp region containing two adja-
cent, putative C/EBP-binding motifs which were termed C/
EBP-1 and C/EBPX by Jones et al. [6]. In this study, C/
EBP-1 and C/EBPX were designated the A site and the B
site, respectively (Fig. 1A). Lysates from the cells transfected
with pGL3pro-mA showed a 4-fold induction following treat-
ment with 0.1 or 1 Wg/ml LPS alone, a 2-fold induction with
100 U/ml IFN-Q alone, and a 13-fold induction with 1 Wg/ml
LPS and 100 U/ml IFN-Q (Fig. 2). Although LPS-induced
transcriptional activity was signi¢cantly decreased, co-stimu-
lation with LPS and IFN-Q maintained the high transcription-
al activity, which was about 60% that of pGL3pro-WT. LPS-
induced enhancer activity was completely abolished in the
cells transfected by pGL3pro-mB. The induction by co-stim-
ulation with 1 Wg/ml LPS and 100 U/ml IFN-Q was also de-
creased signi¢cantly in cells transfected with pGL3pro-mB.
These data indicate that LPS- and IFN-Q-induced transcrip-
tional activation of Mn-SOD is mediated primarily by the B
site, but depends on a potent synergistic e¡ect by factors
interacting with both the A site and B sites within the
TNFRE.
Fig. 2. Functional analysis of the Mn-SOD enhancer. NIH3T3 cells
were transfected with pGL3pro, pGL3pro-WT, pGL3pro-mA, or
pGL3pro-mB plasmids. The average promoter activities were gener-
ated from three separate experiments. The S.E.M.s are indicated by
the error bars. Luciferase activities were normalized for the transfec-
tion e⁄ciency with the cotransfected pGL3-TK control vector.
Fig. 3. Anti-C/EBP antibodies supershift the SOD-C/EBP-UB-protein complexes. EMSA using a 32P-labeled SOD-C/EBP-UB probe incubated
with the nuclear extracts from NIH3T3 cells which were left untreated (lanes 1^6), treated with 0.1 Wg/ml LPS and 100 U/ml IFN-Q for 4 h
(lanes 7^12), treated with 0.1 Wg/ml LPS for 4 h (lanes 13^18), or treated with 100 U/ml IFN-Q for 4 h (lanes 19^24). Antibodies to C/EBP K
(lanes 2, 8, 14, and 20), C/EBP L (lanes 3, 6, 9, 12, 15, 18, 21, and 24), C/EBP N (lanes 4, 6, 10, 12, 16, 18, 22, and 24), or CRP-1 (lanes 5,
11, 17, and 23) were added to the extracts prior to the addition of the probe. The arrows indicate the SOD-C/EBP-UB-protein complexes and
the supershifted complex.
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3.2. C/EBP proteins bind to the A site in vitro
To identify factors that interact with the 30-bp region en-
compassing the A and B sites, EMSAs were carried out with
nuclear extracts prepared from the NIH3T3 cells which were
untreated and treated with either or both 0.1 Wg/ml LPS and
100 U/ml IFN-Q. Nuclear extracts from control and treated
cells interacted with 32P-labeled SOD-C/EBP-UB oligonucleo-
tides, forming several bands (Fig. 3). Anti-C/EBP L and N
antibodies were able to supershift the medium-sized bands
of complexes, especially complexes from cells treated with
LPS alone (lanes 15, 16, and 18) or with LPS in combination
with IFN-Q (lanes 9, 10, and 12). However anti-C/EBP K and
anti-CRP-1 antibodies had no e¡ect. We performed supershift
analysis using 32P-labeled SOD-UB oligonucleotides contain-
ing only the B site instead of the SOD-C/EBP-UB probe.
When the nuclear extracts prepared from untreated and
treated cells were incubated with the SOD-UB probe, none
of the antibodies of C/EBP bound to the complexes (data
not shown). These results indicate that both L/L and L/N iso-
forms of C/EBP binds to the A site.
3.3. p65 and p50 NF-UB bind to the B site in vitro
To characterize the nuclear factors which bind to the B site,
we performed competition and supershift EMSA using the
SOD-UB probe. Binding of the complexes to the SOD-UB
probe was sequence-speci¢c since it was blocked by an excess
of an unlabeled SOD-UB oligonucleotide but not by an excess
of an unlabeled oligonucleotide containing a mutation within
the B site (Mut-UB) (Fig. 4, lanes 7^9). We also used a NF-UB
consensus oligonucleotide as an unlabeled competitor. This
oligonucleotide prevented formation of the SOD-UB-protein
complexes (lane 10), suggesting a possible involvement of
NF-UB in the assembly of the complexes. To con¢rm the
possibility, supershift analysis was carried out with the
SOD-UB probe. Antibody to p65 supershifted the complexes
(lane 11) and antibody to p50 partially disrupted the DNA
binding of the complex (lane 12). These results suggested NF-
UB as the inducible binding factor interacting with the B site
despite the lack of identi¢cation of canonical NF-UB sites
within this region.
4. Discussion
In this study, we identi¢ed the critical cis-acting element
interacting with NF-UB, distinct from the previously described
NF-UB transcription factor-binding site.
We showed here that the 5P C/EBP-related region of the
TNFRE is necessary for LPS and IFN-Q induction using a
transfection assay. The importance of the C/EBP-related bind-
ing sites, the A site and the B site, which regulate Mn-SOD
gene expression, was demonstrated by the ability of mutations
at these sites to substantially reduce transcriptional activity
induced by LPS alone or LPS in combination with IFN-Q.
Expression of C/EBP L and C/EBP N is elevated in several
tissues as a part of the acute phase response [9,10]. Trans-
fection studies and EMSAs demonstrated that LPS-mediated
activation of C/EBP N in addition to C/EBP L is important for
LPS-mediated transcriptional activation of Mn-SOD through
the A site, the C/EBP protein-binding site.
Mutation of the B site reduced LPS-mediated transcription-
al activity to nearly the control level, suggesting that the B site
is indispensable for LPS-mediated transcriptional activation
through the TNFRE. Despite the lack of identi¢cation of a
classic NF-UB-binding site around the B site, we found evi-
dence that NF-UB proteins could bind to the B site, using
competition and supershift EMSAs. The B site has a strong
homology with regulatory regions, such as IFNc-C3 and IFN-
Q UB of the human IFN-Q gene [11], FP-b of the macrophage
in£ammatory protein 1K promoter [12], and IL-6UB of the
interleukin-6 (IL-6) gene promoter [13], which bind to NF-
UB proteins in vitro. Interestingly, several promoters of im-
mune or acute phase-responsive genes, such as the IL-6 gene
[14], the interleukin-8 (IL-8) gene [15], and the angiotensino-
gen gene [16], have adjacent or overlapping binding sites for
NF-UB and C/EBP. Such interactions may be implied by the
close proximity of the NF-UB- and C/EBP-family binding sites
in the Mn-SOD enhancer.
IFN-Q alone had little e¡ect on the NF-UB and C/EBP bind-
ing to the A and B sites, and did not induce Mn-SOD gene
expression through transcriptional activation. However, IFN-
Q augments the ability of LPS to induce the gene expression
and the transcriptional activation of Mn-SOD, as well as in-
terleukin-12 (IL-12) p40 [17] and inducible-type NO synthase
[18,19]. A signi¢cant supershift was seen with extracts from
cells treated with both LPS and IFN-Q for 20 min using anti-
body to p65 (data not shown), suggesting that co-stimulation
with LPS and IFN-Q could enhance IUB degradation or NF-
Fig. 4. Identi¢cation of NF-UB proteins binding to the B site.
EMSA using a 32P-labeled SOD-UB probe incubated with the nu-
clear extracts from NIH3T3 cells either untreated (lanes 1^6), or
LPS- and IFN-Q-cotreated for 4 h (lanes 7^12). A 200-fold molar
excess of a SOD-UB oligonucleotide (lanes 2 and 8), a Mut-UB oli-
gonucleotide (lanes 3 and 9), or a NF-UB consensus oligonucleotide
(lanes 4 and 10) was used as an unlabeled competitor. Antibodies
to the p65 subunit (lanes 5 and 11) or the p50 subunit (lanes 6 and
12) were added to the extracts prior to the addition of the probe.
The SOD-UB-protein complexes and the supershifted complex are
indicated.
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UB translocation to increase e¡ective NF-UB activity and Mn-
SOD gene expression. Furthermore, the induction by LPS and
IFN-Q was retained in both mutants, although it was reduced
in pGL3pro-mB, indicating that there is a potential for addi-
tional interactions between the NF-UB site and other factors
binding sites. These theories remain to be studied.
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